medigraphic.com
ISSN 0210-5187 (Electronic)

2018, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2018; 46 (1)

Pityriasis Rubra Pilaris.
Something more than a disorder of queratinization?

García-Briz MI, García-Ruiz R, Zayas-Gávila AI, Mateu-Puchades A

Language: Spanish
References: 24
Page: 7-12
PDF size: 277.75 Kb.


ABSTRACT

Introduction: Pytiriasis rubra pilaris (PRP) is a cutaneous disease of unknown ethiology. It has been related to autoimmune diseases, psoriasis and cancer. Objective: The main objective of this observational and retrospective study is to describe the characteristics of our patients with PRP, as well as the possible relationship with the previously described diseases. Material and methods: In this study we review the diagnosed cases of PRP in the Department of Dermatology of the «Hospital Universitario Doctor Peset», from January the first of 2008 to January the first of 2017. Results: A total of 21 patients were included, with a mean age of presentation of 43 years. The most common form is the classic adult type. 4 patients had a history of psoriasis. 4 cases had an autoimmune disease. 2 patients had a history of neoplastic disease, one of them following a parallel course with PRP. Conclusions: In PRP patients, we must consider the coexistence of psoriasis and autoimmune diseases. It is also important to discard the presence of a neoplasic subjacent process, mainly if clinical presentation is atypical or responds poorly to treatment.


REFERENCES

  1. Bella-Navarro R, Pellicer-Oliver ZM, Martín-Hernández JM, Jordá-Cuevas E. Pitiriasis rubra pilaris. Diagnóstico y tratamiento. Piel. 2013; 28: 20-30.

  2. Griffiths WAD. Pityriasis rubra pilaris. Clin Exp Dermatol. 1980; 5: 105-112.

  3. Miralles ES, Núñez M, De las Heras ME, Pérez B, Moreno R, Ledo A. Pityriasis rubra pilaris and human immunodeficiency virus infection. Br J Dermatol. 1995; 133: 990-993.

  4. Griffiths WA, Ozluer S. Pityriasis rubra pilaris. Ann Dermatol Venereol. 2001; 128: 931-934.

  5. Lister RK, Perry JD, Cerio R. Pityriasis rubra pilaris and a seronegative polyarthritis. Br J Dermatol. 1997; 137: 318-319.

  6. Albert MR, Mackool BT. Pityriasis rubra pilaris. Int J Dermatol. 1999; 38: 1-11.

  7. Evangelou G, Murdoch SR, Palamaras I, Rhodes LE. Photoaggravated pityriasis rubra pilaris. Photodermatol Photoimmunol Photomed. 2005; 21: 272-274.

  8. Petrof G, Almaani N, Archer CB, Griffiths WA, Smith CH. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists. J Eur Acad Dermatol Venereol. 2013; 27: 131-135.

  9. Di Stefani A, Galluzo M, Talamonti M, Chiricozzi A, Costanzo A, Chimenti S. Long-term ustekinumab treatment for refractory type I pytiriasis rubra pilaris. J Dermatol Case Rep. 2013; 7: 5-9.

  10. Chowdhary M, Davila U, Cohen DJ. Usetkinumab as an alternative treatment option for chronic pytiriasis rubra pilaris. Case Reo Dermatol. 2015; 7: 46-50.

  11. Schuster D, Pfister-Wartha A, Bruckner-Tuderman L, Schempp CM. Successful treatment of refractory pityriasis rubra pilaris with secukinumab. JAMA Dermatol. 2016; 152: 1278-1280.

  12. Krase IZ, Cavanaugh K, Curiel-Lewandrowski C. Treatment of refractory pityriasis rubra pilaris with novel phosphodiesterase 4 (PDE4) inhibitor apremilast. JAMA Dermatol. 2016; 152: 348-350.

  13. Inoue N, Dainichi T, Fujisawa A, Nakano H, Sawamura D, Kabashima K. Card 14 Glu 138 mutation in familiar pytiriasis rubra pliaris does not warrant differentiation from familiar psoriasis. J Dermatol. 2016; 43: 187-189.

  14. Ferrándiz C, Carrascosa JM, Toro M. Prevalencia de la psoriasis en España en la era de los agentes biológicos. Actas Dermosifiliogr. 2014; 105: 504-509.

  15. Stamatis G, Chiolou Z, Sefanaki C, Zakopoulou N, Rigopoulos D, Kontochristopoulos G. Pityriasis rubra pilaris presenting with an abnormal autoinmune profile: two cases reports. J Med Case Reports. 2009; 3: 123.

  16. Chan H, Liu FT, Naguwa S. A review of pityriasis rubra pilaris and rheumatologic associations. Clin Rev Immunol. 2004; 11: 57-60.

  17. Hazini AR, Rongioletti F, Rebora A. Pityriasis rubra pilaris and vitiligo in Down’s syndrome. Clin Exp Dermatol. 1988; 13: 334-335.

  18. Garretson CB, Machan ML, Krejci-Manwaring J, Aires D, Tonkovic-Capin V. Letter: Adenocarcinoma of the lung associated with pityriasis rubra pilaris. Dermatol Online J. 2011; 17 (11): 14.

  19. Kurzydlo AM, Gillespie R. Paraneoplastic pityriasis rubra pilaris in association with bronchogenic carcinoma. Australas J Dermatol. 2004; 45 (2): 130-132.

  20. Batinac T, Kujundzić M, Peternel S, Cabrijan L, Troselj-Vukić B, Petranović D. Pityriasis rubra pilaris in association with laryngeal carcinoma. Clin Exp Dermatol. 2009; 34: 917-919.

  21. Batchelor RJ, Yung A, Merchant W, Goodfield MJ. Pityriasis rubra pilaris as the initial presentation of renal cell carcinoma? Clin Exp Dermatol. 2005; 30: 442-443.

  22. Sharma S, Weiss GR, Paulger B. Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma. Dermatology. 1997; 194: 166-167.

  23. Reinhardt LA, Rosen T. Pityriasis rubra pilaris as the initial manifestation of leukemia. Cutis. 1983; 31: 100-102.

  24. Bar-Ilan E, Gat A, Sprecher E, Zeeli T. Paraneoplastic pityriasis rubra pilaris: case report and literatura. Clin Exp Dermatol. 2017; 42: 54-57.




2020     |     www.medigraphic.com